Nomi Health vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
Nomi Health provides self-insured employers a direct primary care and benefits platform with transparent pricing, bypassing traditional insurance middlemen to reduce total healthcare spend.
About
Nomi Health operates a direct-to-employer healthcare model that contracts directly with care providers — primary care clinics, labs, imaging centers, and specialists — to offer self-insured employers transparent, pre-negotiated prices without insurance company intermediaries. The platform combines a provider network, benefits administration technology, and care navigation to give employers full visibility into what they are spending and why, replacing opaque managed care contracts with itemized, market-rate pricing.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.